Advertisement
Screener

SPYRE THERAPEUTICS, INC. (SYRE) Number of Operating Segments

2.8 / 5 stars · 68/120 Roast Me

SPYRE THERAPEUTICS, INC. Number of Operating Segments

SPYRE THERAPEUTICS, INC. (SYRE) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfOperatingSegments · last filed 2026-08-04

  • SPYRE THERAPEUTICS, INC. number of operating segments for the quarter ending 2023-03-31 was 1.00 Segment, a 0.00% change year-over-year.
  • SPYRE THERAPEUTICS, INC. number of operating segments for the quarter ending 2022-03-31 was 1.00 Segment, a 0.00% change year-over-year.
  • SPYRE THERAPEUTICS, INC. number of operating segments for the quarter ending 2021-03-31 was 1.00 Segment, a 0.00% change year-over-year.
  • SPYRE THERAPEUTICS, INC. number of operating segments for the quarter ending 2020-03-31 was 1.00 Segment, a 0.00% change year-over-year.
  • SPYRE THERAPEUTICS, INC. number of operating segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
  • SPYRE THERAPEUTICS, INC. number of operating segments for fiscal 2021 was 1.00 Segment, a 0.00% change from fiscal 2020.
  • SPYRE THERAPEUTICS, INC. number of operating segments for fiscal 2020 was 1.00 Segment, a 0.00% change from fiscal 2019.
  • SPYRE THERAPEUTICS, INC. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.

Segment

Period endNumber of Operating Segments 3 monthNumber of Operating Segments 6 monthNumber of Operating Segments 9 monthNumber of Operating Segments 12 month
2023-06-301.00 Segment
10-Q · filed 2023-08-11
2023-03-311.00 Segment
10-Q · filed 2023-05-11
2022-12-311.00 Segment
10-K · filed 2023-03-02
2022-09-301.00 Segment
10-Q · filed 2022-11-03
2022-06-301.00 Segment
10-Q · filed 2022-08-04
2022-03-311.00 Segment
10-Q · filed 2022-05-05
2021-12-311.00 Segment
10-K · filed 2022-03-08
2021-09-301.00 Segment
10-Q · filed 2021-11-04
2021-06-301.00 Segment
10-Q · filed 2021-08-05
2021-03-311.00 Segment
10-Q · filed 2021-05-10
2020-12-311.00 Segment
10-K · filed 2021-03-18
2020-09-301.00 Segment
10-Q · filed 2020-11-05
2020-06-301.00 Segment
10-Q · filed 2020-08-10
2020-03-311.00 Segment
10-Q · filed 2020-05-07
2019-12-311.00 Segment
10-K · filed 2020-02-24
2019-09-301.00 Segment
10-Q · filed 2019-11-06
2019-06-301.00 Segment
10-Q · filed 2019-08-06
2019-03-311.00 Segment
10-Q · filed 2019-05-07
2018-12-311.00 Segment
10-K · filed 2019-03-07
2018-09-301.00 Segment
10-Q · filed 2018-11-08
2018-06-301.00 Segment
10-Q · filed 2018-08-09
2018-03-311.00 Segment
10-Q · filed 2018-05-08
2017-12-311.00 Segment
10-K · filed 2018-03-13
2017-09-301.00 Segment
10-Q · filed 2017-11-07
2017-06-301.00 Segment
10-Q · filed 2017-08-09
2017-03-311.00 Segment
10-Q · filed 2017-05-09
2016-12-311.00 Segment
10-K · filed 2017-03-23
2016-09-301.00 Segment
10-Q · filed 2016-11-09
2016-06-301.00 Segment
10-Q · filed 2016-08-09
2016-03-311.00 Segment
10-Q · filed 2016-05-19

segment

Period endNumber of Operating Segments 3 monthNumber of Operating Segments 6 monthNumber of Operating Segments 9 monthNumber of Operating Segments 12 month
2026-06-301.00 segment
10-Q · filed 2026-08-04
2026-03-311.00 segment
10-Q · filed 2026-05-05
2025-12-311.00 segment
10-K · filed 2026-02-19
2025-09-301.00 segment
10-Q · filed 2025-11-04
2025-06-301.00 segment
10-Q · filed 2025-08-05
2025-03-311.00 segment
10-Q · filed 2025-05-08
2024-12-311.00 segment
10-K · filed 2025-02-27
2024-09-301.00 segment
10-Q/A · filed 2024-11-18
2024-06-301.00 segment
10-Q/A · filed 2024-11-18
2024-03-311.00 segment
10-Q/A · filed 2024-11-18
2023-12-311.00 segment
10-K/A · filed 2024-11-18
2023-09-301.00 segment
10-Q · filed 2023-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
CYTOKINETICS INC (CYTK)United States$9.130B-11.86